GlobalDeal

Aprogen

Biotechnology · Seongnam, South Korea

aprogen.com

About Aprogen

Aprogen is a biotechnology company focused on developing innovative solutions in the field of biopharmaceuticals. The company specializes in the research, development, and commercialization of biologics, particularly in the areas of monoclonal antibodies and recombinant proteins. Aprogen aims to address unmet medical needs through its advanced technologies and expertise in protein engineering. The company is committed to high-quality standards and adheres to rigorous regulatory requirements to ensure the safety and efficacy of its products. With a strong emphasis on research and development, Aprogen collaborates with various academic institutions and industry partners to drive innovation and bring new therapies to market. The company’s pipeline includes several promising candidates that target a range of diseases, including cancer and autoimmune disorders. Aprogen is dedicated to improving patient outcomes and enhancing the quality of life through its cutting-edge biopharmaceutical solutions.

Company facts

Industry
Biotechnology
Sub-industries
Biopharmaceuticals, Monoclonal Antibodies, Recombinant Proteins, Protein Engineering, Clinical Research
Location
Seongnam, South Korea
Employees
51–200
Founded
2001

Products and services

Open Aprogen in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in South Korea

All 342 Biotechnology companies in South Korea →